Cdk1/5 Inhibitor – 10 mg

Brand:
Cayman
CAS:
40254-90-8
Storage:
-20
UN-No:
Non-Hazardous - /

Cyclin-dependent kinases (Cdks) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy.{21810} Cdk1/5 Inhibitor is a pyrazolo [3,4-b] quioxaline that inhibits Cdk1/cyclin B and Cdk5/p25 (IC50s = 600 and 400 nM, respectively).{30416} It less potently inhibits GSK3β (IC50 = 1 µM) and does not block Cdc25 activity.{30416} This compound is used to help define the roles of Cdk1 and Cdk5 in various signaling pathways.{30414,30415,30417}  

 

Available on backorder

SKU: - Category:

Description

Inhibitor of Cdk1/cyclin B and Cdk/p25 (IC50s = 600 and 400 nM, respectively)


Formal name: 1H-pyrazolo[3,4-b]quinoxalin-3-amine

Synonyms:  Cyclin-dependent kinase 1/5 Inhibitor|NSC 693868

Molecular weight: 185.2

CAS: 40254-90-8

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Kinase Inhibitors|CDKs||Product Type|Biochemicals|Kinase Inhibitors|GSK3||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cell Biology|Cell Cycle